DNA Sequencing Testing Used to Detect Residual AML Prior to Transplant
This course discusses how DNA sequencing can assay specific mutations in acute myeloid leukemia (AML) that would allow physicians to appropriately counsel patients and tailor treatment regimens.
Click CE Information to start the course. Post Test and Evaluation must be completed to earn certificate of completion.